Welcome to the Bioasis Technologies Hub On AGORACOM

Free
Message: Armagen reports early positive Phase II data for AGT-181

Trial shows ArmaGen biologic improves cognition in Hurler syndrome patients

I can see this being interpreted both ways. Positive: Proof of concept that trojan horse technologies yield positive clinical data for LSD programs in humans. Negative: BiOasis is not at the same clinical stage as Armagen. I'm curious for others thoughts on this.

BearDownAZ

Share
New Message
Please login to post a reply